Objectives To study of strengthening kidney and activating circulation therapy on patients with parkinson’s disease.
Methods A multi-centre, randomised, placebo-controlled, double-blind clinical study was undertaken. 96 PD patients were enrolled and randomly divided into treatment group and placebo group, both groups based on Madopar treatment. All patients were treated for 9 months, including 6 months’ follow-up period. Scale of symptoms in PD was measured to observe the effects of strengthening kidney and activating circulation therapy on patients with parkinson’s disease. Security indicators for drug adverse effects were also measured before and after treatment.
Results The treatment group showed a higher efficacy than the placebo group in improving symptoms in PD (P<0.01), effective power 87.65%. No adverse effects were found in this trial.
Conclusions SKAC can markedly improve symptoms in patients with Parkinson’s disease. The effects were obvious along with the process of treatment.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.